Oncocyte Share Price Today
(NASDAQ: OCX)

Name: Oncocyte Share Price Today (NASDAQ: OCX) - Oncocyte Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Oncocyte share price is $3.62 & ₹314.83 as on 6 Mar 2025, 2.30 'hrs' IST

$3.62

▲

0.43

(13.48%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Oncocyte share price in Dollar and Rupees. Guide to invest in Oncocyte stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Oncocyte, along with analyst recommendations, forecasts, and comprehensive financials.

Oncocyte share price movements

Today's Low: $2.97
Today's High: $3.95
$3.62
17.95%
Downside
Day's Volatility :24.81%
Upside
8.35%
52 Weeks Low: $1.92
52 Weeks High: $3.95
$3.62
46.91%
Downside
52 Weeks Volatility :51.34%
Upside
8.35%

Oncocyte (OCX) Returns

Period	Oncocyte Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	57.39%	3.7%	0.0%
6 Months	18.69%	-2.8%	0.0%
1 Year	20.27%	2.5%	0.0%
3 Years	-85.63%	12.9%	-11.6%

Oncocyte (OCX) Key Statistics

in dollars & INR

Previous Close	$3.19
Open	$3.17
Today's High	$3.95
Today's Low	$2.9702
Market Capitalization	$91.2M
Today's Volume	$224.0K
52 Week High	$3.95
52 Week Low	$1.922
Revenue TTM	$709.0K
EBITDA	$-21.6M
Earnings Per Share (EPS)	$-5.11
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-165.32%

How to invest in Oncocyte Stock (OCX) from India?

It is very easy for Indian residents to invest directly in Oncocyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oncocyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oncocyte or OCX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oncocyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oncocyte shares which would translate to 0.240 fractional shares of Oncocyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oncocyte, in just a few clicks!

Returns in Oncocyte (OCX) for Indian investors in Rupees

The Oncocyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Oncocyte investment value today

Current value as on today

₹1,25,215

Returns

₹25,215

(+25.21%)

Returns from Oncocyte Stock

₹20,266 (+20.27%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Oncocyte (OCX)

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Oncocyte Stock from India on INDmoney has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Oncocyte

BROADWOOD CAPITAL Inc
21.83%
Awm Investment Company Inc
2.71%
PURA VIDA INVESTMENTS, LLC
2.29%
Vanguard Group Inc
0.85%
Geode Capital Management, LLC
0.48%
BlackRock Inc
0.28%

Analyst Recommendation on Oncocyte

Buy

62%Buy

37%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Oncocyte(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Oncocyte Stock (OCX)

What analysts predicted

Upside of 13.95%

Target:

$4.13

Current:

$3.62

Insights on Oncocyte Stock (Ticker Symbol: OCX)

Price Movement
In the last 7 days, OCX stock has moved up by 40.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 104.0K → 115.0K (in $), with an average increase of 9.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -4.53M → -13.49M (in $), with an average decrease of 197.9% per quarter
OCX vs TMO (3 yr)
In the last 3 years, Oncocyte Corp has experienced a drawdown of -86.2%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 82.0%

Oncocyte Technicals Summary

Sell

Neutral

Buy

Oncocyte is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Oncocyte (OCX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Oncocyte Corp	69.95%	18.69%	20.27%	-85.63%	-91.92%
Agilent Technologies Inc.	-13.96%	-8.56%	-13.48%	-2.94%	78.81%
Idexx Laboratories, Inc.	-5.98%	-6.81%	-21.57%	-15.48%	80.06%
Thermo Fisher Scientific, Inc.	-9.71%	-13.63%	-11.38%	-1.97%	77.48%
Danaher Corp.	-2.07%	-20.46%	-16.74%	-19.95%	48.71%
Iqvia Holdings Inc.	-7.09%	-25.1%	-26.53%	-14.22%	49.88%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Oncocyte Corp	NA	NA	0.0	0.0	-1.65	-0.19	NA	0.73
Agilent Technologies Inc.	29.02	29.02	2.0	5.57	0.21	0.08	0.01	21.13
Idexx Laboratories, Inc.	41.39	41.39	4.36	11.97	0.58	0.23	NA	19.55
Thermo Fisher Scientific, Inc.	31.65	31.65	2.02	23.33	0.13	0.05	0.0	130.22
Danaher Corp.	38.92	38.92	2.05	7.65	0.08	0.04	0.01	68.9
Iqvia Holdings Inc.	24.81	24.81	0.98	11.89	0.23	0.05	NA	34.45

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Oncocyte Corp	Buy	$91.2M	-91.92%	NA	0.0%
Agilent Technologies Inc.	Buy	$36.1B	78.81%	29.02	19.27%
Idexx Laboratories, Inc.	Buy	$35.9B	80.06%	41.39	22.78%
Thermo Fisher Scientific, Inc.	Buy	$194.9B	77.48%	31.65	14.77%
Danaher Corp.	Buy	$147.2B	48.71%	38.92	16.33%
Iqvia Holdings Inc.	Buy	$32.8B	49.88%	24.81	8.91%

About Oncocyte

OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Organization	Oncocyte
Employees	43
CEO	Dr. Michael D. West Ph.D.
Industry	Health Technology

Management People of Oncocyte

Name	Title
Mr. Joshua Riggs	President, CEO & Director
Mr. James Liu	Senior Director, Controller & Principal Accounting Officer
Dr. Ekkehard Schutz M.D., Ph.D.	Chief Science Officer
Ms. Andrea Susan James	Chief Financial Officer
Mr. Yuh-Min Chiang Ph.D.	Chief Technology Officer
Mr. Peter Hong	VP, General Counsel & Secretary
Ms. Sandra O'Donald	Senior Vice President of Business Operations
Dr. Paul R. Billings FACP, M.D.	Consulting Chief Medical Officer
Dr. Michael D. West Ph.D.	Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.

Important FAQs about investing in OCX Stock from India :

What is Oncocyte share price today?

Oncocyte share price today stands at $3.62, Open: $3.17 ; Previous Close: $3.19 ; High: $3.95 ; Low: $2.97 ; 52 Week High: $3.95 ; 52 Week Low: $1.92.

The stock opens at $3.17, after a previous close of $3.19. The stock reached a daily high of $3.95 and a low of $2.97, with a 52-week high of $3.95 and a 52-week low of $1.92.

Can Indians buy Oncocyte shares?

Yes, Indians can invest in the Oncocyte (OCX) from India.

With INDmoney, you can buy Oncocyte at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Oncocyte at zero transaction cost.

How can I buy Oncocyte shares from India?

It is very easy to buy Oncocyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oncocyte (OCX) be purchased?

Yes, you can buy fractional shares of Oncocyte with INDmoney app.

What are the documents required to start investing in Oncocyte stocks?

To start investing in Oncocyte, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.